Dr. Derek Chew
Biography
Derek Chew, MD MSc FRCPC FHRS, is a Cardiac Electrophysiologist at the Foothills Medical Center and an Assistant Professor at the University of Calgary in the Departments of Cardiac Sciences, Medicine, and Community Health Sciences. He is also an Associate Editor for the American Heart Journal and currently serves on the Canadian Heart Rhythm Society Device Committee.
Education and Training
Dr. Chew completed his medical degree at the University of Toronto, and his clinical fellowships in Cardiology and Cardiac Electrophysiology at the University of Calgary. He received his Master of Science in Health Economics, Outcomes & Management from the London School of Economics and subsequently completed a Banting postdoctoral research fellowship at the Duke Clinical Research Institute.
Research Interests and Expertise
Dr. Chew’s research focuses on applied health economics, health technology assessment, processes of care delivery and the implications of cardiac disorders on resource utilization. His current research interests include quality indicators and access to care for atrial fibrillation, economic burden of cardiac implantable electronic device infections, and trial-based and model-based cost-effectiveness analyses of cardiac technologies and therapeutics.
Contact
Key Publications
- Chew DS, Li Y, Bigelow R, Cowper PA, Anstrom KJ, Daniels MR, Davidson-Ray L, Hernandez AF, O’Connor CM, Armstrong PW, Mark DB for the VICTORIA Study Group. Cost-Effectiveness of Vericiguat in Patients with Heart Failure with Reduced Ejection Fraction: The VICTORIA Randomized Clinical Trial. Circulation 2023;148
- Chew DS, Piccini JP, Au F, Frazier-Mills CG, Michalski J, Varma N. Alert-driven versus scheduled remote monitoring of implantable cardiac defibrillators: A Cost-Consequence Analysis from the TRUST Trial. Heart Rhythm 2023;20(3):440-447.
- Chew DS, Zhou K, Pokorney SD, Matchar DB, Vemulapalli S, Allen LA, Jackson KP, Samad Z, Patel MR, Freeman JV, Piccini JP. Left Atrial Appendage Occlusion versus Oral Anticoagulation in Atrial Fibrillation: A Decision Analysis. Ann Intern Med 2022;175(9):1230-1239.
- Chew DS, Li Y, Cowper PA, Anstrom KJ, Piccini JP, Poole JE, Daniels MR, Monahan KH, Davidson-Ray L, Bahnson TD, Al-Khalidi H, Lee KL, Packer DL, Mark DB, on behalf of the CABANA Investigators. Cost-Effectiveness of Catheter Ablation versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial. Circulation 2022;146:535-547